The store will not work correctly when cookies are disabled.
4-[3-(4-Methylphenyl)-5-oxo-4-propyl-2-thioxoimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
ID: ALA1086578
PubChem CID: 46889900
Max Phase: Preclinical
Molecular Formula: C21H18F3N3OS
Molecular Weight: 417.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCC1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C)cc1
Standard InChI: InChI=1S/C21H18F3N3OS/c1-3-4-18-19(28)27(20(29)26(18)15-8-5-13(2)6-9-15)16-10-7-14(12-25)17(11-16)21(22,23)24/h5-11,18H,3-4H2,1-2H3
Standard InChI Key: QXZFJKVKRATIPW-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
7.0569 -2.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0557 -3.5898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7706 -4.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4870 -3.5894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4841 -2.7588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7688 -2.3497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3412 -2.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6266 -1.9320 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3409 -4.0018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6268 -3.5887 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.3403 -4.8268 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.1281 -3.2047 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.1547 -4.0664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1620 -4.8913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9488 -5.1393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4279 -4.4676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9370 -3.8046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4989 -5.3821 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1849 -3.0177 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.2518 -4.4586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6717 -5.1710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4967 -5.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9028 -4.4425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4778 -3.7294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6542 -3.7413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7277 -4.4326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2107 -5.9217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6641 -6.5396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9259 -7.3220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 8 3 0
1 7 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
4 13 1 0
14 18 2 0
2 9 1 0
17 19 2 0
16 20 1 0
4 5 1 0
9 10 1 0
20 21 2 0
2 3 1 0
21 22 1 0
9 11 1 0
22 23 2 0
5 6 2 0
23 24 1 0
9 12 1 0
24 25 2 0
25 20 1 0
13 14 1 0
23 26 1 0
6 1 1 0
15 27 1 0
1 2 2 0
27 28 1 0
3 4 2 0
28 29 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 417.46 | Molecular Weight (Monoisotopic): 417.1123 | AlogP: 5.19 | #Rotatable Bonds: 4 |
Polar Surface Area: 47.34 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.95 | CX Basic pKa: ┄ | CX LogP: 5.99 | CX LogD: 5.99 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.64 | Np Likeness Score: -1.33 |
References
1. Jung ME, Ouk S, Yoo D, Sawyers CL, Chen C, Tran C, Wongvipat J.. (2010) Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)., 53 (7): [PMID:20218717] [10.1021/jm901488g] |